A fascinating glimpse inside the life-and-death business ofbiotechnology. "A tour-de-force for anyone who is interested in the biotechindustry. I applaud the enormous achievement of CynthiaRobbins-Roth." -Frederick Frank, Senior Managing Director Vice Chair, Lehman Brothers "From Alchemy to IPO tells the dramatic story of thisrevolutionary industry as only an insider can." -George Rathmann,President and CEO, ICOS Corporation, Chairman Emeritus, Amgen Written by a well-known industry insider, From Alchemy to IPOaddresses the coming-of-age of biotech products and companies andtraces the history of biotechnology from its early inception in theseventies to today's heyday of new solutions and breakthroughtreatments. It describes the amazing entrepreneurial trail ofproduct development, novel business models, and critical trialsthat eventually pave the way to market. This is the first book toaccurately record the inner workings of anindustry-biotechnology-that's on the verge of living up to
Programming Legend Charles Petzold unlocks the secrets of theextraordinary and prescient 1936 paper by Alan M. Turing Mathematician Alan Turing invented an imaginary computer knownas the Turing Machine; in an age before computers, he explored theconcept of what it meant to be computable, creating the field ofcomputability theory in the process, a foundation of present-daycomputer programming. The book expands Turing’s original 36-page paper withadditional background chapters and extensive annotations; theauthor elaborates on and clarifies many of Turing’s statements,making the original difficult-to-read document accessible topresent day programmers, computer science majors, math geeks, andothers. Interwoven into the narrative are the highlights of Turing’sown life: his years at Cambridge and Princeton, his secret work incryptanalysis during World War II, his involvement in seminalcomputer projects, his speculations about artificial intelligence,his arrest and prosecution for the cr
